S22-067 Granulysin nanobodies to prevent the development of heart attack and stroke Stanford scientists designed a nanobody platform to inhibit the activity of granulysin, a protein that is often found in arterial plaque and released by T cells, to prevent the development of atherosclerosis such as heart attack and strokes. Patricia Nguyen Charles Chan Mark Davis
S10-337 Potent MET receptor agonists and antagonists Stanford Reference: Dockets S10-337 and S10-337B: Jennifer Cochran Douglas Jones Ping-Chuan Tsai